Toxicity management strategies for next-generation novel therapeutics in multiple myeloma

The therapeutic options available for patients with multiple myeloma have greatly expanded over the past decade and incorporating these novel agents into routine clinical practice has significantly improved outcomes. The next generation of therapeutics is available for relapsed and refractory patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinbach, Mary, Julian, Kelley, McClune, Brian, Sborov, Douglas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289924/
https://www.ncbi.nlm.nih.gov/pubmed/35860442
http://dx.doi.org/10.1177/20406207221100659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289924/
https://www.ncbi.nlm.nih.gov/pubmed/35860442
http://dx.doi.org/10.1177/20406207221100659

Ejemplares similares